1. Home
  2. SURG vs INTS Comparison

SURG vs INTS Comparison

Compare SURG & INTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo SurgePays Inc.

SURG

SurgePays Inc.

HOLD

Current Price

$1.66

Market Cap

47.6M

ML Signal

HOLD

Logo Intensity Therapeutics Inc.

INTS

Intensity Therapeutics Inc.

HOLD

Current Price

$0.40

Market Cap

24.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SURG
INTS
Founded
2006
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Advertising
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
47.6M
24.0M
IPO Year
N/A
2023

Fundamental Metrics

Financial Performance
Metric
SURG
INTS
Price
$1.66
$0.40
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
3
Target Price
$9.75
$4.33
AVG Volume (30 Days)
146.3K
3.1M
Earning Date
11-12-2025
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$50,372,555.00
N/A
Revenue This Year
$7.13
N/A
Revenue Next Year
$122.51
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.05
$0.19
52 Week High
$3.47
$3.17

Technical Indicators

Market Signals
Indicator
SURG
INTS
Relative Strength Index (RSI) 41.91 45.52
Support Level $1.58 $0.37
Resistance Level $1.95 $0.43
Average True Range (ATR) 0.20 0.05
MACD 0.04 -0.01
Stochastic Oscillator 45.59 13.19

Price Performance

Historical Comparison
SURG
INTS

About SURG SurgePays Inc.

Surgepays Inc is a fintech company focused on the underbanked community. It provides services to financial technology, telecommunications, and digital media companies. Its operating segment includes Mobile Virtual Network Operators that provide mobile broadband (internet connectivity), voice and SMS text messaging to both subsidized and direct retail prepaid customers through SurgePhone Wireless, LLC and Torch Wireless, LLC; Comprehensive Platform Services provide financial technology and a wireless top-up platform to independently owned convenience stores throughout the country; and Others. It generates the majority of its revenue from the Mobile Virtual Network Operators segment.

About INTS Intensity Therapeutics Inc.

Intensity Therapeutics Inc is a clinical-stage biotechnology company pioneering a new immune-based approach to treat solid tumor cancers. The company leverages its DfuseRxtechnology platform to create new, proprietary drug formulations that, following direct injection, rapidly disperse throughout a tumor and diffuse therapeutic agents into cancer cells. Intensity's product candidates have the potential to induce an adaptive systemic immune response that not only attacks the injected tumor, but also non-injected tumors. Their pipeline is focused on realizing the full potential of INT230-6 in metastatic and local disease settings to help cancer patients with unmet medical need.

Share on Social Networks: